Hi, what are you looking for?
The new rules will facilitate safer access to substances like psilocybin, but many in need won't qualify, experts say
The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services
Research funded by MindMed suggests some antidepressants can reduce the unwanted side effects of psychedelics
The agency says it supports research into the substances and it's necessary for the FDA to approve new quotas
When asked why patient requests for legal psilocybin are being denied or delayed, the agency said studies are the best route for access